Phase II Trial of Concurrent Nivolumab in Urothelial Bladder Cancer With Radiation Therapy in Localized/Locally Advanced Disease for Chemotherapy Ineligible Patients [NUTRA]
Phase of Trial: Phase II
Latest Information Update: 22 May 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms NUTRA
- 31 Aug 2018 Biomarkers information updated
- 12 May 2018 Status changed from not yet recruiting to recruiting.
- 11 Feb 2018 Planned initiation date changed from 2 Feb 2018 to 16 Feb 2018.